Julia D Wulfkuhle Selected Research

Julia D Wulfkuhle Research Topics

Disease

28	Neoplasms (Cancer) 11/2021 - 11/2002
14	Breast Neoplasms (Breast Cancer) 12/2021 - 11/2002
4	Neoplasm Metastasis (Metastasis) 07/2011 - 04/2008
3	Pathologic Complete Response 12/2021 - 01/2018
3	Carcinogenesis 11/2012 - 04/2003
2	Prostatic Neoplasms (Prostate Cancer) 09/2011 - 06/2009
1	Triple Negative Breast Neoplasms 12/2021
1	Hyperglycemia 10/2021
1	Lung Neoplasms (Lung Cancer) 10/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2017
1	Disease Progression 10/2014
1	Schizophrenia (Dementia Praecox) 04/2012
1	Brain Neoplasms (Brain Tumor) 07/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2009
1	Colorectal Neoplasms (Colorectal Cancer) 08/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2007
1	Carcinoma (Carcinomatosis) 04/2005
1	Ovarian Neoplasms (Ovarian Cancer) 11/2003
1	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2002

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2002
8	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2003
7	Pharmaceutical PreparationsIBA 10/2021 - 01/2007
4	ErbB Receptors (EGF Receptor)IBA 06/2013 - 11/2009
3	Hormones (Hormone)IBA 12/2021 - 03/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 10/2021
3	Phosphotransferases (Kinase)IBA 06/2013 - 08/2009
3	Lapatinib (GW572016)FDA Link 01/2013 - 11/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 10/2017
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2013
2	Insulin (Novolin)FDA Link 01/2020 - 06/2013
2	neratinibIBA 01/2018 - 01/2013
2	Heme (Haem)IBA 10/2017 - 10/2017
2	CytochromesIBA 10/2017 - 10/2017
2	BiguanidesIBA 10/2017 - 10/2017
2	PhosphoproteinsIBA 11/2009 - 04/2008
1	durvalumabIBA 12/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	olaparibIBA 12/2021
1	Trastuzumab (Herceptin)FDA Link 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	pertuzumabIBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ganitumabIBA 10/2021
1	Biological ProductsIBA 10/2021
1	BMS 754807IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2020
1	AcidsIBA 10/2017
1	EicosanoidsIBA 10/2017
1	Cytochrome P-450 CYP3AIBA 10/2017
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2017
1	Arachidonic Acid (Vitamin F)IBA 10/2017
1	ibrutinibIBA 06/2017
1	Drug CombinationsIBA 06/2017
1	venetoclaxIBA 06/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2014
1	IntegrinsIBA 06/2013
1	human ERBB2 proteinIBA 01/2013
1	histidine-rich proteinsIBA 01/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2013
1	Tamoxifen FDA LinkGeneric 11/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2012
1	AntibodiesIBA 11/2012
1	Messenger RNA (mRNA)IBA 11/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2011
1	mirdametinibIBA 09/2011
1	GW2974IBA 08/2011
1	Tyrosine (L-Tyrosine)FDA Link 08/2011
1	VimentinIBA 03/2011
1	Mitogen-Activated Protein KinasesIBA 08/2009
1	Protein Isoforms (Isoforms)IBA 08/2009
1	AndrogensIBA 06/2009
1	CaspasesIBA 06/2009
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2009
1	Phospho-Specific AntibodiesIBA 11/2003
1	Mitogen-Activated Protein Kinase 3IBA 11/2003
1	IonsIBA 11/2002
1	Nucleic AcidsIBA 11/2002
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2002
1	GelsIBA 11/2002

Therapy/Procedure

12	Therapeutics 11/2021 - 01/2007
8	Lasers (Laser) 12/2012 - 11/2002
3	Neoadjuvant Therapy 12/2021 - 01/2018
1	Castration 09/2011
1	Drug Therapy (Chemotherapy) 11/2009
1	Colectomy 08/2009